NCT04134429View on ClinicalTrials.gov

Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
Pediatric CancerFebrile NeutropeniaChemotherapy-induced NeutropeniaOncology
Interventions
DEVICE

Everion

The Everion® device, by Biovotion, Zurich, is a on-skin wearable device measuring health data.

Trial Locations (1)

3010

Inselspital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04134429 - Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy | Biotech Hunter | Biotech Hunter